LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $596,000 | +57.3% | 4,544 | +82.6% | 0.05% | +68.8% |
| Q1 2021 | $379,000 | -81.4% | 2,488 | -86.1% | 0.03% | -59.5% |
| Q2 2019 | $2,042,000 | -7.1% | 17,892 | +10.4% | 0.08% | -30.1% |
| Q4 2018 | $2,198,000 | +36.1% | 16,200 | +107.7% | 0.11% | +242.4% |
| Q2 2018 | $1,615,000 | -73.8% | 7,800 | -79.1% | 0.03% | -69.2% |
| Q1 2018 | $6,160,000 | +118.4% | 37,300 | +81.1% | 0.11% | +154.8% |
| Q4 2017 | $2,820,000 | -19.7% | 20,600 | -20.2% | 0.04% | +5.0% |
| Q3 2017 | $3,512,000 | -36.0% | 25,800 | -42.9% | 0.04% | -51.8% |
| Q2 2017 | $5,487,000 | +144.7% | 45,200 | +140.4% | 0.08% | -21.0% |
| Q2 2016 | $2,242,000 | +37.8% | 18,800 | +23.7% | 0.10% | +32.9% |
| Q1 2016 | $1,627,000 | +257.6% | 15,200 | +261.9% | 0.08% | +182.1% |
| Q4 2015 | $455,000 | -63.1% | 4,200 | -70.8% | 0.03% | -69.9% |
| Q3 2015 | $1,233,000 | +166.9% | 14,400 | +140.0% | 0.09% | +111.4% |
| Q1 2015 | $462,000 | – | 6,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |